MCID: RNL101
MIFTS: 67

Renal Cell Carcinoma, Papillary malady

Categories: Genetic diseases, Rare diseases, Nephrological diseases, Cancer diseases

Aliases & Classifications for Renal Cell Carcinoma, Papillary

About this section
Sources:
11Disease Ontology, 12diseasecard, 13DISEASES, 24GeneTests, 26GTR, 30ICD10 via Orphanet, 34LifeMap Discovery®, 36MedGen, 38MeSH, 39MESH via Orphanet, 44NCIt, 47NIH Rare Diseases, 51OMIM, 53Orphanet, 61SNOMED-CT, 63The Human Phenotype Ontology, 67UMLS, 68UMLS via Orphanet, 69UniProtKB/Swiss-Prot
See all MalaCards sources

Aliases & Descriptions for Renal Cell Carcinoma, Papillary:

Name: Renal Cell Carcinoma, Papillary 51 12
Papillary Renal Cell Carcinoma 34 11 47 53 13 67
Papillary Renal Cell Carcinoma, Sporadic 38 67
Renal Cell Carcinoma, Xp11-Associated 51 67
Renal Cell Carcinoma Xp11-Associated 69 26
Papillary Renal Cell Adenocarcinoma 47 53
Renal Cell Carcinoma, Papillary, 1 51 12
Renal Cell Carcinoma Papillary 1 69 26
Renal Cell Carcinoma Papillary 69 26
Rccp 47 69
Renal Cell Carcinoma, Papillary, 1, Familial and Somatic 51
Carcinoma Associated with Mitf/tfe Translocation 53
Papillary Renal Cell Carcinoma, Bilateral - 47
Papillary Renal Cell Carcinoma, Familial - 47
Papillary Renal Cell Carcinoma, Sporadic - 47
Papillary Renal Cell Carcinoma, Multiple - 47
Hereditary Papillary Renal Cell Carcinoma 53
 
Sporadic Papillary Renal Cell Carcinoma 11
Papillary Renal Carcinoma, Malignant - 47
Hereditary Papillary Renal Carcinoma 67
Translocation Renal Cell Carcinoma 53
Chromophilic Renal Cell Carcinoma 69
Papillary Renal Adenocarcinoma 67
Chromophil Carcinoma of Kidney 11
Papillary Kidney Carcinoma 11
Papillary Renal Carcinoma 24
Translocation Carcinoma 53
Papillary Kidney Cancer 67
Papillary Renal Cancer 24
Renal Cell Carcinoma 67
Renal Adenocarcinoma 47
Hprcc 53
Rccx1 69
Prcc 69

Characteristics:

Orphanet epidemiological data:

53
hereditary papillary renal cell carcinoma:
Inheritance: Autosomal dominant; Age of onset: Adult

HPO:

63
renal cell carcinoma, papillary, 1:
Inheritance: somatic mutation
renal cell carcinoma, papillary:
Inheritance: autosomal dominant inheritance
Onset and clinical course: incomplete penetrance

Classifications:

Orphanet: 53 
Rare renal diseases


External Ids:

Disease Ontology11 DOID:4465
SNOMED-CT61 4797003
UMLS via Orphanet68 C1306837, C2931899
ICD10 via Orphanet30 C64
MESH via Orphanet39 C538614

Summaries for Renal Cell Carcinoma, Papillary

About this section
OMIM:51 Xp11 translocation renal cell carcinomas (RCCX1) are a group of neoplasms distinguished by chromosomal translocations... (300854) more...

MalaCards based summary: Renal Cell Carcinoma, Papillary, also known as papillary renal cell carcinoma, is related to renal cell carcinoma and familial renal papillary carcinoma, and has symptoms including flank pain, flank pain and flank pain. An important gene associated with Renal Cell Carcinoma, Papillary is MET (MET Proto-Oncogene, Receptor Tyrosine Kinase), and among its related pathways are Kit Receptor Signaling Pathway and Glucose / Energy Metabolism. The drugs peginterferon alfa-2b and interferon alfacon-1 have been mentioned in the context of this disorder. Affiliated tissues include kidney, lung and bone, and related mouse phenotypes are embryo and homeostasis/metabolism.

Disease Ontology:11 A renal cell carcinoma that is characterized by the development of multiple, bilateral papillary renal tumors.

NIH Rare Diseases:47 Papillary renal cell carcinoma (PRCC) is a type of cancer that occurs in the kidneys. It accounts for about 10-15% of all renal cell carcinomas.Renal cell carcinomas are a type of kidney cancer that develop in the lining of very small tubes (tubules) in the kidney.The term papillary describes the finger-like projections that can be found in most of the tumors. PRCC can be divided into two types: type 1, which is more common and usually grows more slowly and type 2, which are usually more aggressive .Though the exact cause of papillary renal cell carcinoma is unknown, smoking, obesity, and genetic predisposition conditions (such as hereditary leiomyomatosis and renal cell cancer) may contribute to the development of this type of cancer. Treatment often begins with surgery to remove as much of the cancer as possible, and may be followed by radiation therapy, chemotherapy, biological therapy, or targeted therapy. Last updated: 2/11/2016

UniProtKB/Swiss-Prot:69 Renal cell carcinoma papillary: A subtype of renal cell carcinoma tending to show a tubulo-papillary architecture formed by numerous, irregular, finger-like projections of connective tissue. Renal cell carcinoma is a heterogeneous group of sporadic or hereditary carcinoma derived from cells of the proximal renal tubular epithelium. Renal cell carcinoma Xp11-associated: Renal cell carcinoma is a heterogeneous group of sporadic or hereditary carcinoma derived from cells of the proximal renal tubular epithelium. It is subclassified into clear cell renal carcinoma (non- papillary carcinoma), papillary renal cell carcinoma, chromophobe renal cell carcinoma, collecting duct carcinoma with medullary carcinoma of the kidney, and unclassified renal cell carcinoma. RCCX1 histology shows both clear cells and papillary architecture, often with abundant psammoma bodies, although variable histologic features have been observed.

Description from OMIM:51 605074

Related Diseases for Renal Cell Carcinoma, Papillary

About this section

Diseases related to Renal Cell Carcinoma, Papillary via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 68)
idRelated DiseaseScoreTop Affiliating Genes
1renal cell carcinoma29.2AMACR, ASPSCR1, CA9, CDH16, FH, KIT
2familial renal papillary carcinoma11.1
3acute myeloid leukemia with cebpa somatic mutations10.9TFE3, VHL
4waardenburg syndrome, type 2a10.8MITF, TFE3
5transient hypogammaglobulinemia10.8FH, MET
6embryonal sarcoma10.8KRT7, VHL
7advanced sleep-phase syndrome, familial, 210.8ASPSCR1, MET, TFE3
8myoma10.8FH, MITF
9multilocular clear cell renal cell carcinoma10.8FH, MET
10gars-associated axonal neuropathy10.8FH, VHL
11pediatric ovarian dysgerminoma10.8KRT7, PAX8
12skin glomus tumor10.8KIT, MITF
13biliary tract neoplasm10.8KRT7, PAX8
14central nervous system rhabdomyosarcoma10.8ASPSCR1, KIT, TFE3
15prostate colloid adenocarcinoma10.7KRT7, MME
16kidney cancer10.7
17adult central nervous system choriocarcinoma10.7KRT7, MME
18basophilic carcinoma10.7AMACR, ATM, PAX8
19cervical wilms' tumor10.7AMACR, KRT7, PRCC
20epithelial-myoepithelial carcinoma10.7AMACR, ATM, PAX8
21tumor predisposition syndrome10.7ATM, FH, VHL
22hypervitaminosis a10.7KIT, MITF
23peritonitis10.7KIT, KRT7
24pancreatic serous cystic neoplasm10.7KRT7, VHL
25central nervous system vasculitis10.7MME, PAX8, VHL
26gallbladder leiomyosarcoma10.7FH, MITF, MME
27colon mucinous adenocarcinoma10.7AMACR, KIT
28clear cell adenocarcinoma10.7AMACR, MME, PAX8
29multicentric reticulohistiocytosis10.7KRT7, MME
30hilar cholangiocellular carcinoma10.7CA9, PAX8, VHL
31epithelioid type angiomyolipoma10.7KIT, MITF, MME
32carotid artery dissection10.7AMACR, KRT7, PAX8
33periductal breast myoepitheliosis10.7MME, PAX8
34ovarian stromal hyperthecosis10.7AMACR, PAX8
35malignant biphasic mesothelioma10.7KIT, PAX8
36malignant sertoli-leydig cell tumor10.7KIT, KRT7, MME
37vibratory urticaria10.7KIT, KRT7, MME
38amyloidosis, hereditary, transthyretin-related10.7KIT, KRT7, MET
39heavy chain disease10.7KIT, KRT7, MITF
40ciliary body spindle cell melanoma10.6KIT, MET, MITF
41vestibular gland benign neoplasm10.6KIT, KRT7, MME
42female breast lower-inner quadrant cancer10.6KRT7, MME
43gallbladder papillomatosis10.6KIT, KRT7, MET
44dysembryoplastic neuroepithelial tumor10.6KIT, MME
45hyperaldosteronism10.6ASPSCR1, MITF, PRCC, TFE3, TFEB
46ocular melanoma10.6KIT, MITF, MME, VHL
47cystadenoma10.6CA9, FH, MET, VHL
48brown-vialetto-van laere syndrome10.6KIT, KRT7, MITF
49breast neuroendocrine neoplasm10.6KRT7, MME
50tenosynovitis of foot and ankle10.6AMACR, KIT, MME, PAX8

Graphical network of the top 20 diseases related to Renal Cell Carcinoma, Papillary:



Diseases related to renal cell carcinoma, papillary

Symptoms for Renal Cell Carcinoma, Papillary

About this section


Clinical features from OMIM:

605074,300854

Human phenotypes related to Renal Cell Carcinoma, Papillary:

 63
id Description HPO Frequency HPO Source Accession
1 renal cell carcinoma63 HP:0005584
2 papillary renal cell carcinoma63 HP:0006766

UMLS symptoms related to Renal Cell Carcinoma, Papillary:


flank pain

Drugs & Therapeutics for Renal Cell Carcinoma, Papillary

About this section

Drugs for Renal Cell Carcinoma, Papillary (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 483)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Epinephrineapproved, vet_approvedPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 193351-43-45816
Synonyms:
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol
(-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol
(-)-Adrenalin
(-)-Adrenaline
(-)-Epinephrine
(-)-R-Epinephrine
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-(−)-adrenaline
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
(R)-Adrenaline
(R)-Epinephrine
(−)-adrenaline
02252_FLUKA
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
51-43-4
51-43-4 (FREE BASE)
51028-73-0
A0173
AC-13188
AC1L1L7B
ADR ADRENALINE
ADROP
AI3-19015
Adnephrine
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin in Oil
Adrenalin-Medihaler
Adrenalina
Adrenalina [DCIT]
Adrenaline
Adrenaline (JP15)
Adrenaline/Epinephrine
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
Ana-Guard
Ana-Kit
Antiasthmatique
Asmatane Mist
Asthma meter mist
Asthma-nefrin
Asthmahaler Mist
Asthmanefrin
Astmahalin
Astminhal
BIDD:GT0119
Balmadren
Bernarenin
Biorenine
Bosmin
Brevirenin
Bronkaid
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
CCRIS 4812
CHEBI:28918
CHEMBL679
CID5816
Chelafrin
Citanest Forte
Corisol
D-Epifrin
D-Epinephrine
D00095
DB00668
Drenamist
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
EPIPEN E Z PEN
EPIPEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
Epinephrin
Epinephrine
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine hydrochloride
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
Epipen EZ Pen
Epipen Jr.
Epipen Jr. Auto-Injector
Epirenamine
Epirenan
Epirenin
Epitrate
Eppy
Esphygmogenina
Exadrin
 
Glaucon
Glaucosan
Glauposine
Glycirenan
HSCI1_000215
HSDB 4289
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
Hypernephrin
Hyporenin
IOP
Intranefrin
Iontocaine
Isoptoepinal
Kidoline
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-Adrenaline
L-Adrenaline Base
L-Epinehphrine
L-Epinephrine
L-Epirenamine
L-Methylaminoethanolcatechol
L-epinephrine
LS-156
Levo-Methylaminoethanolcatechol
Levoadrenaline
Levoepinephrine
Levorenen
Levorenin
Levorenine
Levoreninum
Lopac-E-4642
Lyodrin
Lyophrin
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
Micronefrin
Micronephrine
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
NSC 62786
NSC62786
Nephridine
Nieraline
PDSP1_001120
PDSP2_001104
Paranephrin
Primatene
Primatene Mist
R-(-)-Epinephrine
R-Adrenaline
RCRA waste no. P042
Racemic Epinephrine
Racepinephrine
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
SMP1_000227
ST069368
SUS-PHRINE SULFITE-FREE
Scurenaline
Septocaine
Simplene
Sindrenina
Soladren
Sphygmogenin
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Sus-Phrine
Sus-phrine
Susphrine
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
adrenaline
bmse000316
d-Adrenaline
epinephrine
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
l-Epinephine
l-Epinephrine (synthetic)
l-Epirenamine
l-Methylaminoethanolcatechol
levoepinephrine
nchembio747-comp9
2
EverolimusapprovedPhase 4, Phase 3, Phase 2, Phase 11896159351-69-66442177
Synonyms:
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy
07741_FLUKA
159351-69-6
40-O-(2-hydroxyethyl)-rapamycin
42-O-(2-Hydroxyethyl)rapamycin
Afinitor
CERTICAN(R)
CHEMBL1201755
Certican
D02714
DB01590
 
Everolimus
Everolimus (JAN/USAN/INN)
Everolimus [USAN]
LS-143292
MolPort-003-847-342
MolPort-003-925-588
NCGC00167512-01
NVP-RAD-001
RAD 001
RAD-001
RAD-001C
RAD001
RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus
S1120_Selleck
SDZ-RAD
UNII-9HW64Q8G6G
Zortress
everolimus
3
Miconazoleapproved, investigational, vet_approvedPhase 4, Phase 3, Phase 2, Phase 1362422916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
4
Sirolimusapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 1189653123-88-95284616, 6436030, 46835353
Synonyms:
(-)-Rapamycin
(-)-rapamycin
1fkb
1pbk
23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29
3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
53123-88-9
A422989, NSC226080
AC-722
AC1L1JH9
AC1L7MJ9
AC1L9ZMV
AY 22989
AY-22989
AY22989
Ambotz53123-88-9
Antibiotic AY 22989
BIDD:PXR0165
Bio1_000293
Bio1_000782
Bio1_001271
Bio2_000375
Bio2_000855
BiomolKI2_000084
C07909
C51H79NO13
CBiol_002007
CCRIS 9024
CHEBI:100923
CHEBI:9168
CHEMBL413
CID10213190
CID10795871
CID11949238
CID11959112
CID313006
CID478951
CID5040
CID5284616
CID5358081
CID5374464
CID5460439
CID5497196
CID5924240
CID6436030
CID6610270
CID6610346
CID6711160
CID6713081
CID9833581
CID9854379
CID9854380
CID9962926
CID9962928
D00753
DB00877
DE-109
DivK1c_006936
 
FT-0082351
HMS2089A21
HSDB 7284
KBio1_001880
KBio2_000410
KBio2_002978
KBio2_005546
KBio3_000779
KBio3_000780
KBioGR_000410
KBioSS_000410
LCP-Siro
LMPK06000003
LS-143290
MLS000028373
MS-R001
MolMap_000043
MolPort-003-959-433
NCGC00021305-05
NCI60_001851
NCIMech_000355
NSC 226080
NSC226080
Perceiva
QTL1_000069
R0395_SIAL
R0395_SIGMA
RAP
RAPA
RPM
Rapammune
Rapamune
Rapamune (TN)
Rapamycin
Rapamycin (TN)
Rapamycin C-7, analog 4
Rapamycin Immunosuppressant Drug
Rapamycin from Streptomyces hygroscopicus
S1039_Selleck
SIIA 9268A
SILA 9268A
SILA9268A
SMP1_000255
SMR000058564
Sirolimus
Sirolimus (RAPAMUNE)
Sirolimus (USAN/INN)
Sirolimus [USAN:BAN:INN]
Sirolimus, Rapamune,Rapamycin
SpecPlus_000840
UNII-W36ZG6FT64
UNM-0000358684
WY-090217
Wy 090217
heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy
nchembio.100-comp4
nchembio.2007.42-comp2
nchembio.79-comp1
nchembio762-comp1
nchembio883-comp3
rapamycin
sirolimus
5
Sunitinibapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 1500341031-54-7, 557795-19-45329102
Synonyms:
(2S)-2-hydroxybutanedioic acid
1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1)
1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1)
326914-13-0
341031-54-7
5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE
557795-19-4
AC1NS62J
AC1O5CMQ
AKOS005145765
Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1)
CHEBI:38940
CHEBI:550864
CHEMBL1567
CHEMBL535
CID5329102
CID6456015
D06402
D08552
DB01268
DB07417
EN002687
FT-0083555
FT-0083556
I01-1229
K00588a
KS-5022
LS-186078
LS-187023
LS-187648
MolPort-003-986-763
N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate
N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
NCGC00164631-01
 
NSC736511
NSC750690
PDGF TK antagonist
PHA-290940AD
PNU-290940AD
S1042_Selleck
ST51053712
SU 011248
SU 11248
SU-010398
SU-011248 L-malate salt
SU-11248
SU-11248 L-malate salt
SU-11248J
SU-12662
SU010398
SU011248
SU011248 L-malate salt
SU11248
Su-011248
Sunitanib
Sunitinib
Sunitinib (INN)
Sunitinib (free base)
Sunitinib malate
Sunitinib malate (JAN/USAN)
Sunitinib malate [USAN]
Sunitinibum
Sutent
Sutent (TN)
Sutent, SU-11248
TL8002546
UNII-LVX8N1UT73
UNII-V99T50803M
sunitinib
sunitinibum
6
AldesleukinapprovedPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 139785898-30-2, 110942-02-4
Synonyms:
125-L-serine-2-133-interleukin 2 (human reduced)
 
Interleukin-2 aldesleukin
Interleukin-2(2-133),125-ser
Recombinant interleukin-2 human
7
Bevacizumabapproved, investigationalPhase 4, Phase 3, Phase 1, Phase 21968216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
8
GemcitabineapprovedPhase 4, Phase 2, Phase 1197495058-81-460750
Synonyms:
103882-84-4
122111-03-9
2',2'-DiF-dC
2',2'-Difluoro-2'-deoxycytidine
2',2'-Difluorodeoxycytidine
2'-Deoxy-.beta.-D-2',2'-difluorocytidine
2'-Deoxy-2',2'-difluorocytidine
4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one
4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
95058-81-4
AB1004842
AC1L1TUQ
C07650
CCRIS 8984
CHEBI:175901
CHEMBL888
CID60750
Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine
D02368
DB00441
DDFC
DFDC
DFdC
DFdCyd
Folfugem
GEO
Gamcitabine
GemLip
Gemcel
 
Gemcin
Gemcitabin
Gemcitabina
Gemcitabina [INN-Spanish]
Gemcitabine
Gemcitabine (USAN/INN)
Gemcitabine HCl
Gemcitabine hydrochloride
Gemcitabine stereoisomer
Gemcitabinum
Gemcitabinum [INN-Latin]
Gemtro
Gemzar
Gemzar (hydrochloride)
HMS2089P10
HSDB 7567
Inno-D07001
LS-59139
LY 188011
LY-188011
LY188011
NCGC00168784-01
NChemBio.2007.10-comp25
NSC 613327
NSC613327
TL8005979
UNII-B76N6SBZ8R
ZINC18279854
Zefei
gemcitabine
nchembio.573-comp7
nchembio.90-comp2
9
Axitinibapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 1106319460-85-06450551
Synonyms:
319460-85-0
790713-39-2
AC-1539
AC1O51X3
AG 013736
AG-013736
AG-013736, Axitinib
AG-13736
AG013736
Axitinib
C503983
 
CID6450551
EC-000.2322
I14-1971
INLYTA
Inlyta
MolPort-006-392-413
N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide
N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide
S1005_Selleck
ST51054130
UNII-C9LVQ0YUXG
ZINC03816287
axitinib
10
Sorafenibapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 1692284461-73-0216239, 406563
Synonyms:
284461-73-0
4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide
4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate
4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE
AB1004622
AC-1674
AC1L50CF
BAX
BAY 43-9006
BAY 43-9006 (free base)
BAY 43-9006 tosylate salt
BAY 439006
BAY 54-9085 (tosylate salt)
BAY-43-0006
BAY-43-9006
BAY-54-9085
BAY43-9006
BRD-K23984367-001-01-8
Bio-0100
CHEBI:47228
CHEBI:50924
CHEMBL1336
CID216239
 
D08524
DB00398
DB07438
EN002709
I06-0856
K00597a
Kinome_766
LS-186067
LS-187021
LS-187788
MolPort-003-850-270
N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea
N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea
NCGC00167488-01
NSC-724772
NSC747971
Nexavar
STK627350
Sorafenib
Sorafenib (INN)
Sorafenib [INN]
Sorafenib tosylate
Sorafenibum
UNII-9ZOQ3TZI87
ZINC01493878
nchembio.117-comp17
sorafenib
sorafenibum
11
Fentanylapproved, illicit, investigational, vet_approvedPhase 4, Phase 3, Phase 2773437-38-73345
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
1-phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Actiq
BIDD:GT0555
BRN 0494484
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl CII
Fentanyl [INN:BAN]
Fentanyl citrate
Fentanyl-100
Fentanyl-12
Fentanyl-25
 
Fentanyl-50
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
HSDB 3329
IONSYS
JNS020QD
L001275
LS-124439
Matrifen
MolPort-003-847-369
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidyl)propionanilide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenethyl-4-(N-propionylanilino)piperidine
N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
NCGC00168252-01
Nasalfent
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
UNII-UF599785JZ
fentanyl
12
Zoledronic acidapprovedPhase 4, Phase 1, Phase 2290118072-93-868740
Synonyms:
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid
(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid
(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid
(1-hydroxy-2-imidazol-1-yl-phosphonoethyl)phosphonic acid monohydrate
(1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid
118072-93-8
2-(imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid
2-(imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid
AC-1092
AC1L2ACJ
AC1Q6RN3
AKOS005145739
Aclasta
Anhydrous Zoledronic Acid
BIDD:GT0292
BIDD:PXR0134
Bio-0112
Bisphosphonate 3
C088658
CGP 42'446
CGP 42446
CGP 42446A
CGP-42'446
CGP-42446
CHEBI:46557
CHEMBL924
CID68740
D08689
DB00399
 
FT-0082657
HMS2089O09
I06-0710
KS-1132
LS-181815
MolPort-002-885-874
MolPort-003-850-890
NCGC00159521-02
NCGC00159521-03
NSC721517
Novartis brand of zoledronic acid
Reclast
Reclast (TN)
S00092
S1314_Selleck
UNII-70HZ18PH24
ZOL
Zol
Zoledronate
Zoledronic Acid Anhydrous
Zoledronic Acid, Anhydrous
Zoledronic acid
Zoledronic acid (INN)
Zoledronic acid [USAN:INN]
Zometa
Zometa (Novartis)
Zometa (TN)
Zometa Concentrate
Zometa, Zomera, Aclasta and Reclast, Zoledronic Acid
[1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid)
13
nivolumabapprovedPhase 4, Phase 3, Phase 2, Phase 1326946414-94-4
Synonyms:
BMS-936558
 
MDX-1106
ONO-4538
nivolumab
14
Midazolamapproved, illicitPhase 4, Phase 168459467-70-84192
Synonyms:
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate
59467-70-8
8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride
8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine
8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine
AC-18749
AC1L1HMA
BIDD:GT0647
BRN 0625572
Buccolam
C07524
C18H13ClFN3
CHEMBL655
CID4192
D00550
DB00683
DEA No. 2884
Dazolam
Dea No. 2884
 
Dormicum
Dormicum (TN)
EINECS 261-774-5
LS-77780
Midanium
Midazolam
Midazolam (JAN/INN)
Midazolam Base
Midazolam Hcl
Midazolam [INN:BAN:JAN]
Midazolamum
Midazolamum [INN-Latin]
Midosed
MolPort-003-849-219
NCGC00168254-01
Ro 21-3981
TL8003787
UC429_SIGMA
UNII-R60L0SM5BC
Versed
ZINC00001732
midazolam
nchembio747-comp32
15
Dexmedetomidineapproved, vet_approvedPhase 454076631-46-4, 113775-47-668602, 5311068, 56032
Synonyms:
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-trimethylbenzyl)imidazole
(+)-medetomidine
(S)-medetomidine
113775-47-6
4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole
4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
AC1NSJXT
C07450
CHEBI:4466
CHEMBL778
CID5311068
D00514
DEXMEDETOMIDINE
 
Dexdor (T)
Dexmedetomidin
Dexmedetomidina
Dexmedetomidine
Dexmedetomidine (USAN/INN)
Dexmedetomidinum
Dexmédétomidine
MPV 1440
MPV-1440
Medetomidina [Spanish]
Medetomidine
Medetomidinum [Latin]
NCGC00025347-01
PRECEDEX
Precedex (TN)
Tocris-2023
ZINC04632106
16
NicotineapprovedPhase 4105054-11-5942, 89594
Synonyms:
(−
(+)-Nicotine
(-)-3-(1-Methyl-2-pyrrolidyl)pyridine
(-)-3-(N-Methylpyrrolidino)pyridine
(-)-Nicotine
(-)-Nicotine solution
(2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine
(R)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(R,S)-Nicotine
(S)-(-)-NICOTINE, 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE
(S)-(-)-Nicotine
(S)-(−)-nicotine
(S)-3-(1-methylpyrrolidin-2-yl)pyridine
(S)-3-(N-methylpyrrolidin-2-yl)pyridine
(S)-Nicotine
(−)-nicotine
)-1-Methyl-2-(3-pyridyl)pyrrolidine
)-Nicotine
)-Nicotine solution
1-Methyl-2-(3-pyridal)-Pyrrolidine
1-Methyl-2-(3-pyridal)-pyrrolidene
1-Methyl-2-(3-pyridiyl)pyrrolidine
1-Methyl-2-(3-pyridyl)pyrrolidine
1uw6
2'-beta-H-Nicotine
3-(1-Methyl-2-pyrollidinyl)pyridine
3-(1-Methyl-2-pyrrolidinyl)-Pyridine
3-(1-Methyl-2-pyrrolidinyl)pyridine
3-(1-Methylpyrrolidin-2-yl)pyridine
3-(2-(N-methylpyrrolidinyl))pyridine
3-(N-Methylpyrollidino)pyridine
3-(N-Methylpyrrolidino)pyridine
3-(N-methylpyrollidino)pyridine
3-N-Methylpyrrolidine
3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
36733_FLUKA
36733_RIEDEL
434F7990-3240-4A43-ACEC-E6CC1E495FA0
46343_FLUKA
46343_RIEDEL
54-11-5
AC1L3I79
AC1Q3ZOC
AI3-03424
BB_NC-0777
BIDD:GT0599
BRD-K05395900-322-02-1
Black Leaf
Black Leaf 40
C00745
CCRIS 1637
CHEBI:17688
CHEMBL3
CID89594
CPD000059074
Campbell's Nico-Soap
Caswell No. 597
Commit
D-Nicotine
D03365
DL-tetrahydronicotyrine
Destruxol
Destruxol Orchid Spray
EINECS 200-193-3
ENT 3,424
EPA Pesticide Chemical Code 056702
Emo-Nik
Flux Maag
Fumeto bac
Fumetobac
HSDB 1107
Habitrol
Habitrol (TN)
L(-)-nicotine
L(−)-nicotine
L-3-(1-Methyl-2-pyrrolidyl)pyridine
 
L-Nicotine
LS-202
MLS001055457
MLS001335905
Mach-Nic
Methyl-2-pyrrolidinyl)pyridine
Micotine
MolPort-000-744-731
N3876_SIGMA
N5511_FLUKA
N5511_SIGMA
NCGC00090693-01
NCGC00090693-02
NCGC00090693-03
NCGC00090693-04
NCGC00090693-05
NCGC00090693-06
NCGC00090693-07
NCT
NICOTINE AND SALTS
NSC 5065
NSC97238
Niagara P.A. Dust
Nic-Sal
Nico-Dust
Nico-Fume
Nicocide
Nicoderm
Nicoderm Cq
Nicoderm Patch
Nicorette
Nicorette Plus
Nicotin
Nicotina
Nicotina [Italian]
Nicotine
Nicotine (USP)
Nicotine (compounds related to)
Nicotine Alkaloid
Nicotine Patch
Nicotine Polacrilex
Nicotine [BSI:ISO]
Nicotine [UN1654]
Nicotine [UN1654] [Poison]
Nicotine [USAN]
Nicotrol
Nicotrol Inhaler
Nicotrol Ns
Nictoine patch
Nikotin
Nikotin [German]
Nikotyna
Nikotyna [Polish]
Ortho N-4 Dust
Ortho N-5 Dust
PDSP1_000113
PDSP1_000465
PDSP2_000463
PDSP2_000555
Prostep
R)-(+)-Nicotine
RCRA waste no. P075
RCRA waste number P075
SAM002564224
SDCCGMLS-0066911.P001
SMR000059074
Tendust
Transdermal Nicotine
UN1654
a -N-Methylpyrrolidine
a-N-Methylpyrrolidine
alpha-N-Methylpyrrolidine
beta-Pyridyl-alpha-N-methyl pyrrolidine
beta-Pyridyl-alpha-N-methylpyrrolidine
bmse000105
delta-Nicotine
nicotine
nicotine replacement patch
17
Bupivacaineapproved, investigationalPhase 4, Phase 2, Phase 311312180-92-9, 38396-39-32474
Synonyms:
( inverted exclamation markA)-bupivacaine
(+-)-Bupivacaine
(1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
(RS)-bupivacaine
(±)-bupivacaine
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
15233-43-9
2180-92-9
38396-39-3
AB00053674
AC-2096
AC1L1DRE
AC1Q5LX4
AH 250
AKOS001637202
AR-1A0242
Anekain
BPBio1_000298
BRD-A01636364-003-05-2
BSPBio_000270
BSPBio_002607
Bio-0886
Bloqueina
Bucaine
Bucaine (TN)
Bupivacaina
Bupivacaina [INN-Spanish]
Bupivacaine (INN)
Bupivacaine Carbonate
Bupivacaine HCL
Bupivacaine HCL KIT
Bupivacaine Monohydrochloride, Monohydrate
Bupivacaine [INN:BAN]
Bupivacainum
Bupivacainum [INN-Latin]
Bupivan
C07529
C18H28N2O
CBupivacaine
CHEBI:3215
CHEMBL1098
CID2474
Carbostesin
D07552
DB00297
DL-Bupivacaine
DUR-843
 
DepoBupivacaine
DivK1c_000758
EINECS 218-553-3
EINECS 253-911-2
HMS2090F12
IDI1_000758
KBio1_000758
KBio2_002004
KBio2_004572
KBio2_007140
KBio3_001827
KBioGR_001516
KBioSS_002004
KST-1A4609
L000695
LAC-43
LS-109841
LS-2222
MLS001361336
Marcaina
Marcaine
Marcaine HCL
Marcaine Spinal
MolPort-004-955-820
NCGC00178579-01
NCGC00178579-02
NINDS_000758
NSC119660
Prestwick0_000305
Prestwick1_000305
Prestwick2_000305
Prestwick3_000305
SMR000058218
SPBio_001558
SPBio_002489
Sensorcaine
Sensorcaine-MPF
Sensorcaine-MPF Spinal
Spectrum2_001589
Spectrum3_000974
Spectrum4_001098
Spectrum5_001483
Spectrum_001524
Transdur-Bupivacaine
UNII-Y8335394RO
Win 11318
Win 11318 HCl
bupivacaine
cBupivacaine
dl-1-Butyl-2',6'-pipecoloxylidide
racemic bupivacaine
18
Nicotinamideapproved, NutraceuticalPhase 4, Phase 3, Phase 2, Phase 190298-92-0936
Synonyms:
.beta.-Pyridinecarboxamide
11032-50-1
123574-63-0
1yc5
3 Pyridinecarboxamide
3-Carbamoylpyridine
3-Pyridinecarboxamide
3-Pyridinecarboxylic acid amide
37321-14-5
47865U_SUPELCO
55600-01-6
63748-44-7
72340_FLUKA
72340_SIGMA
72347_FLUKA
78731-47-2
98-92-0
A186B02E-6C70-4E54-9739-79398D439AAA
AC-907/25014114
AC1L1ACZ
AC1Q4ZFV
AI3-02906
Acid amide
Amid kyseliny nikotinove
Amid kyseliny nikotinove [Czech]
Amide PP
Aminicotin
Amixicotyn
Amnicotin
Astra Brand of Niacinamide
Austrovit PP
B 3, Vitamin
B3, Vitamin
BB_NC-2290
Benicot
C00153
C6H6N2O
CCRIS 1901
CHEBI:17154
CHEMBL1140
CID936
CPD000058212
D00036
D009536
DB02701
DEA No. 1405
Delonin Amide
Delonin amide
Dipegyl
Dipigyl
EINECS 202-713-4
EINECS 234-265-0
Endobion
Enduramide
Factor pp
HMS2052M21
HMS2090B05
HMS2093H03
HSDB 1237
Hansamid
I02-1741
I02-2250
InChI=1/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9
Inovitan PP
Jenapharm Brand of Niacinamide
Jenapharm, Nicotinsaureamid
LS-2051
MLS000069714
Mediatric
Merck Brand of Niacinamide
MolMap_000061
MolPort-001-783-876
N0078
N0636_SIGMA
N2142_SIGMA
N3376_SIGMA
N5535_SIAL
NAM
NCGC00093354-03
NCGC00093354-04
NSC 13128
NSC13128
NSC27452
Nandervit-N
Niacevit
Niacinamide
Niacinamide (USP)
Niacinamide Astra Brand
Niacinamide Jenapharm Brand
Niacinamide Merck Brand
 
Niacinamide Pharmagenix Brand
Niacinamide [USAN]
Niacinamide, Nicotinic acid amide, Nicotinamide
Niacotinamide
Niamide
Niavit PP
Nicamide
Nicamina
Nicamindon
Nicasir
Nicobion
Nicofort
Nicogen
Nicomidol
Nicosan 2
Nicosylamide
Nicota
Nicotamide
Nicotilamide
Nicotililamido
Nicotinamid
Nicotinamida
Nicotinamida [INN-Spanish]
Nicotinamide
Nicotinamide (JP15/INN)
Nicotinamide (Niacinamide)
Nicotinamide, niacin, vitamin B3
Nicotinamide-carbonyl-14C
Nicotinamidum
Nicotinamidum [INN-Latin]
Nicotine acid amide
Nicotine amide
Nicotinic acid amide
Nicotinic amide
Nicotinsaeureamid
Nicotinsaureamid
Nicotinsaureamid Jenapharm
Nicotinsaureamid [German]
Nicotol
Nicotylamide
Nicotylamidum
Nicovel
Nicovit
Nicovitina
Nicovitol
Nicozymin
Nictoamide
Nikasan
Nikazan
Niko-tamin
Nikotinamid
Nikotinsaeureamid
Nikotinsaeureamid [German]
Niocinamide
Niozymin
PP-Faktor
Papulex
Pelmin
Pelmine
Pelonin amide
Pharmagenix Brand of Niacinamide
Propamine A
Pyridine-3-carboxylic acid amide
S1899_Selleck
SAM001246860
SGCUT00176
SMR000058212
Savacotyl
UNII-25X51I8RD4
Vi-Nicotyl
Vi-noctyl
Vitamin B
Vitamin B (VAN)
Vitamin B 3
Vitamin B3 amide
Vitamin H1
Vitamin PP
WLN: T6NJ CVZ
Witamina PP
ZINC00005878
b-Pyridinecarboxamide
beta-Pyridinecarboxamide
bmse000281
m-(Aminocarbonyl)pyridine
nchembio.154-comp4
nchembio.73-comp6
niacin - Vitamin B3
niacinamide
nicotinamide
pyridine-3-carboxamide
to_000073
vitamin PP
19
Niacinapproved, investigational, nutraceuticalPhase 4, Phase 3, Phase 2, Phase 190659-67-6938
Synonyms:
3-Carboxylpyridine
3-Carboxypyridine
3-Pyridinecarboxylate
3-Pyridinecarboxylic acid
3-Pyridylcarboxylate
3-Pyridylcarboxylic acid
3-carboxypyridine
Acide Nicotinique
Acido nicotinico
Acidum Nicotinicum
Akotin
Anti-pellagra vitamin
Apelagrin
Daskil
Efacin
Enduracin
Linic
M-Pyridinecarboxylic Acid
Niac
Niacin
Niacine
Niacor
Nicacid
Nicamin
Nicangin
 
Nico-Span
Nicobid
Nicocap
Nicodelmine
Nicolar
Niconacid
Nicosan 3
Nicotinate
Nicotinic Acid
Nicotinic acid
Nicotinipca
Nicyl
Nikotinsaeure
Nyclin
P.P. factor
PP Factor
Pellagra preventive factor
Pellagrin
Pelonin
Pyridine-beta-carboxylic acid
Slo-niacin
Vitamin B3
Wampocap
beta-Pyridinecarboxylic acid
pyridine-β-carboxylic acid
β-pyridinecarboxylic acid
20
Folic Acidapproved, nutraceutical, vet_approvedPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 1427959-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
21
Caffeineapproved, NutraceuticalPhase 438058-08-22519
Synonyms:
07E4FB58-FD79-4175-8E3D-05BF96954522
1,3,7-Trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione
1,3,7-Trimethylpurine-2,6-dione
1,3,7-Trimethylxanthine
1,3,7-trimethyl-2,6-dioxopurine
1,3,7-trimethylpurine-2,6-dione
1,3,7-trimethylxanthine
1-3-7-TRIMETHYLXANTHINE
1-Methyl-Theobromine
1-methyltheobromine
137X
1gfz
1l5q
1l7x
27602_FLUKA
2a3b
3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion
3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
3,7-dihydro-1,3,7-trimethyl-1H-purine
5-26-13-00558 (Beilstein)
58-08-2
7-Methyl Theophylline
7-Methyltheophylline
7-methyltheophylline
71701-02-5
75035_FLUKA
95789-13-2
A.S.A. and Codeine Compound
AC-12774
AC1L1DV2
AC1Q3Z23
ACon1_000085
AI3-20154
AKOS000121334
Alert-Pep
Alert-pep
Anacin Maximum Strength
Anhydrous caffeine
Anhydrous caffeine (JP15)
Anhydrous caffeine (TN)
Anoquan
BIDD:ER0554
BIDD:GT0632
BIDD:PXR0172
BIM-0050216.0001
BRD-K02404261-001-02-7
BRD-K02404261-001-03-5
BRN 0017705
BSPBio_001921
Berlin-Chemie Brand of Caffeine
Bio-0579
Bio1_000473
Bio1_000962
Bio1_001451
Bristol-Myers Squibb Brand of Caffeine
C 0750
C07481
C0750_SIAL
C1778_SIAL
C2042
C6035_FLUKA
C6035_SIGMA
C7731_SIAL
C8960_SIAL
CCRIS 1314
CFF
CHEBI:27732
CHEMBL113
CID2519
CU-01000012617-3
Cafamil
Cafcit
Cafecon
Cafeina
Cafergot
Cafeína
Caffedrine
Caffedrine Caplets
Caffein
Caffeina
Caffeina [Italian]
Caffeine (USP)
Caffeine (natural)
Caffeine Pure
Caffeine [BAN:JAN]
Caffeine solution
Caffeine, Anhydrous
Caffeine, Monohydrate
Caffeine, Synthetic
Caffeine, anhydrous
Caffeine, synthetic
Caffeinum
Caffine
Cafipel
Caféine
Coffein
Coffein [German]
Coffeine
Coffeinum
Coffeinum N
Coffeinum Purrum
Compound 65
D002110
D00528
DB00201
DHC Plus
DHCplus
Darvon Compound
Darvon Compound-65
Dasin
Dexitac
Dexitac Stay Alert Stimulant
Dhc Plus
Diurex
DivK1c_000730
Durvitan
EINECS 200-362-1
EU-0100228
Eldiatric C
Enerjets
Ercatab
Esgic
Esgic-Plus
FEMA No. 2224
Femcet
Fioricet
Fiorinal
GlaxoSmithKline Brand of Caffeine
Guaranine
HMS1920I09
HMS2091O11
HMS502E12
HSDB 36
Hycomine
Hycomine Compound
I14-4386
 
IDI1_000730
Invagesic
Invagesic Forte
KBio1_000730
KBio2_001781
KBio2_004349
KBio2_006917
KBio3_001141
KBioGR_002325
KBioSS_001781
Keep Alert
Kofein
Kofein [Czech]
Koffein
Koffein [German]
L000155
LS-237
Lanorinal
Lopac-C-0750
Lopac0_000228
MEGxp0_001350
MLS001055341
MLS001056714
MLS001066409
Mateina
Mateína
Maximum Strength Snapback Stimulant Powders
Medigesic Plus
Merck dura Brand of Caffeine
Methyltheobromide
Methyltheobromine
Methylxanthine theophylline
Midol Maximum Strength
Migergot
Miudol
MolMap_000054
MolPort-000-730-850
Monohydrate Caffeine
Monomethyl Derivative of Theophylline
Monomethyl derivative of Theophylline
NCGC00015208-01
NCGC00015208-02
NCGC00015208-04
NCGC00015208-14
NCGC00090699-01
NCGC00090699-02
NCGC00090699-03
NCGC00090699-04
NCGC00090699-05
NCGC00090699-06
NCGC00090699-07
NCGC00090699-08
NCGC00090699-09
NCGC00168808-01
NCGC00168808-02
NCI-C02733
NCIOpen2_008255
NINDS_000730
NSC 5036
NSC5036
Natural Caffeinum
Nix Nap
No Doz
No-Doz
Nodaca
Nodoz Maximum Strength Caplets
Norgesic
Norgesic Forte
Organex
Orphengesic
Orphengesic Forte
P-A-C Analgesic Tablets
PDSP1_001016
PDSP1_001235
PDSP2_001000
PDSP2_001219
Passauer Brand of Caffeine
Pep-Back
Percoffedrinol N
Percutafeine
Phensal
Pierre Fabre Brand of Caffeine
Probes1_000150
Probes2_000128
Propoxyphene
Propoxyphene Compound 65
Propoxyphene Compound-65
Quick Pep
Quick-Pep
Refresh'n
Republic Drug Brand of Caffeine
SDCCGMLS-0064595.P001
SDCCGMLS-0064595.P002
SK 65 Compound
SK-65 Compound
SMR000326667
SPBio_001222
SPECTRUM1500155
STK177283
Seid Brand of Caffeine
Spectrum2_001261
Spectrum3_000321
Spectrum4_001782
Spectrum5_000423
Spectrum_001301
Stim
Synalgos-Dc
TNP00310
Thein
Theine
Theobromine ME
Theobromine Me
Theophylline ME
Theophylline Me
Theophylline, 7-methyl
Thompson Brand 1 of Caffeine
Thompson Brand 2 of Caffeine
Tirend
Tri-Aqua
Triad
UNII-3G6A5W338E
Ultra Pep-Back
Vivarin
W222402_ALDRICH
WLN: T56 BN DN FNVNVJ B1 F1 H1
Wake-Up
Wigraine
Xanthine, 1,3,7-trimethyl
ZINC00001084
bmse000206
cafeine
caffeine
caffenium
component of Cafergot
nchembio.243-comp7
nchembio.63-comp5
nchembio774-comp2
teina
teína
22Antimetabolites, AntineoplasticPhase 4, Phase 3, Phase 1, Phase 27171
23AntimetabolitesPhase 4, Phase 3, Phase 1, Phase 211774
24Neurotransmitter AgentsPhase 4, Phase 2, Phase 1, Early Phase 117734
25Liver ExtractsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 13868
26VitaminsPhase 4, Phase 3, Phase 2, Phase 15095
27RacepinephrinePhase 4, Phase 2, Phase 3, Phase 1, Early Phase 1933
28Interferon-alphaPhase 4, Phase 3, Phase 2, Phase 11139
29Pharmaceutical SolutionsPhase 4, Phase 3, Phase 2, Phase 17793
30ImmunoglobulinsPhase 4, Phase 3, Phase 2, Phase 16045
31Imatinib MesylatePhase 4, Phase 2, Phase 1594123596
32Epinephryl boratePhase 4, Phase 2, Phase 3, Phase 1, Early Phase 1933
33Antibodies, MonoclonalPhase 4, Phase 3, Phase 2, Phase 13795
34AntibodiesPhase 4, Phase 3, Phase 2, Phase 16045
35Protein Kinase InhibitorsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 13612
36interferonsPhase 4, Phase 3, Phase 2, Phase 12137
37AnalgesicsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 111287
38Analgesics, Non-NarcoticPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 16260
39Anti-HIV AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 13100
40Immunosuppressive AgentsPhase 4, Phase 3, Phase 2, Phase 112770
41Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 121402
42Angiogenesis Modulating AgentsPhase 4, Phase 3, Phase 2, Phase 14072
43Anti-Bacterial AgentsPhase 4, Phase 3, Phase 2, Phase 110884
44Antibiotics, AntitubercularPhase 4, Phase 3, Phase 2, Phase 16972
45Antifungal AgentsPhase 4, Phase 3, Phase 2, Phase 13615
46Blood SubstitutesPhase 4246
47Anti-Retroviral AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 13232
48HormonesPhase 4, Phase 2, Phase 1, Early Phase 113979
49Nicotinic AcidsPhase 4, Phase 3, Phase 2, Phase 1906
50Trace ElementsPhase 4, Phase 3, Phase 2, Phase 15802

Interventional clinical trials:

(show top 50)    (show all 1358)
idNameStatusNCT IDPhase
1Study to the Optimal Duration of Therapy With Oral Angiogenesis InhibitorsUnknown statusNCT00777504Phase 4
2Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab TreatmentCompletedNCT02056587Phase 4
3SUTENT® In The First Line Treatment Of Renal Cell CarcinomaCompletedNCT00460798Phase 4
4Interleukin-2 in Treating Patients With Metastatic Kidney CancerCompletedNCT00006864Phase 4
5Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2.CompletedNCT01339962Phase 4
6Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone MetastasisCompletedNCT00172003Phase 4
7Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or PazopanibCompletedNCT01514448Phase 4
8Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell CarcinomaCompletedNCT00706706Phase 4
9Sorafenib in Elderly mRCCCompletedNCT01728948Phase 4
10Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer PatientsCompletedNCT01402089Phase 4
11Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal TumoursCompletedNCT02016391Phase 4
12Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit SmokingCompletedNCT00365508Phase 4
13Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic FactorsRecruitingNCT02700568Phase 4
14Post Marketing Surveillance for ICE-SENSE™3 a Cryotherapy Treatment of Renal Cell CarcinomaRecruitingNCT02399124Phase 4
15Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia MethodRecruitingNCT02988219Phase 4
16A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.RecruitingNCT01206764Phase 4
17Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF TherapyRecruitingNCT02570789Phase 4
18Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell CarcinomaRecruitingNCT02555748Phase 4
19First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell CarcinomaRecruitingNCT01521715Phase 4
20A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell CancerRecruitingNCT02982954Phase 4
21A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell CarcinomaActive, not recruitingNCT02596035Phase 4
22Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)Active, not recruitingNCT01266837Phase 4
23Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell CarcinomaTerminatedNCT00930345Phase 4
24Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE)TerminatedNCT02338570Phase 4
25Cost Effectiveness Of Sunitinib In Central America And CaribbeanTerminatedNCT01033981Phase 4
26Phase IV Randomization to On-Going Treatment to Evaluate Sustained SorafenibTerminatedNCT00352859Phase 4
27Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino PatientsTerminatedNCT01073644Phase 4
28Hydroxyethyl Starch and Renal Function After Laparoscopic NephrectomyTerminatedNCT01486550Phase 4
29Study to Observe Safety and Efficacy of Nexavar in Treatment of Kidney CancerWithdrawnNCT01353794Phase 4
30A Post Marketing Surveillance As Required By Philippine Food And Drug AdministrationWithdrawnNCT01781442Phase 4
31Exercise for Patients With Renal Cell Cancer Receiving SunitinibUnknown statusNCT00869011Phase 3
32Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell CarcinomaUnknown statusNCT01481870Phase 3
33Caphosol in Oral Mucositis Due to Targeted TherapyUnknown statusNCT01265810Phase 3
34Chemotherapy Before and After Surgery in Treating Children With Wilm's TumorUnknown statusNCT00047138Phase 3
35Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' TumorUnknown statusNCT00003804Phase 3
36TroVax Renal Immunotherapy Survival TrialCompletedNCT00397345Phase 3
37Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney CancerCompletedNCT00492258Phase 3
38Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainCompletedNCT00538850Phase 3
39Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC)CompletedNCT00478114Phase 3
40AE-941 in Treating Patients With Metastatic Kidney CancerCompletedNCT00005995Phase 3
41Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney CancerCompletedNCT00002473Phase 3
42Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney CancerCompletedNCT00416429Phase 3
43Interleukin-2 in Treating Patients With Metastatic Kidney CancerCompletedNCT00018941Phase 3
44Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney CancerCompletedNCT00002737Phase 3
45Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney CancerCompletedNCT00416871Phase 3
46Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00005966Phase 3
47Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney CancerCompletedNCT00053807Phase 3
48Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney CancerCompletedNCT00053820Phase 3
49Survival Study Of Oncophage® vs. Observation In Patients With Kidney CancerCompletedNCT00033904Phase 3
50Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)CompletedNCT00072046Phase 3

Search NIH Clinical Center for Renal Cell Carcinoma, Papillary

Inferred drug relations via UMLS67/NDF-RT45:


Cochrane evidence based reviews: papillary renal cell carcinoma, sporadic

Genetic Tests for Renal Cell Carcinoma, Papillary

About this section

Genetic tests related to Renal Cell Carcinoma, Papillary:

id Genetic test Affiliating Genes
1 Renal Cell Carcinoma, Papillary, 126
2 Renal Cell Carcinoma, Xp11-Associated26
3 Papillary Renal Cell Carcinoma26
4 Papillary Renal Carcinoma24 MET

Anatomical Context for Renal Cell Carcinoma, Papillary

About this section

MalaCards organs/tissues related to Renal Cell Carcinoma, Papillary:

35
Kidney, Lung, Bone, Brain, Prostate, Endothelial, Thyroid

Animal Models for Renal Cell Carcinoma, Papillary or affiliated genes

About this section

MGI Mouse Phenotypes related to Renal Cell Carcinoma, Papillary:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:000538010.3ATM, KIT, MET, MITF, NONO, PAX8
2MP:00053769.6AKR1C3, AMACR, ATM, FH, KIT, KRT7
3MP:00107689.6AMACR, ATM, CA9, FH, KIT, MET
4MP:00028739.4KIT, MET, MITF, NONO, PAX8, TFE3

Publications for Renal Cell Carcinoma, Papillary

About this section

Articles related to Renal Cell Carcinoma, Papillary:

idTitleAuthorsYear
1
Expression of AKR1C3 in renal cell carcinoma, papillary urothelial carcinoma, and Wilms' tumor. (20126582)
2009

Variations for Renal Cell Carcinoma, Papillary

About this section

UniProtKB/Swiss-Prot genetic disease variations for Renal Cell Carcinoma, Papillary:

69 (show all 15)
id Symbol AA change Variation ID SNP ID
1METp.Met1131ThrVAR_006286rs121913668
2METp.Val1188LeuVAR_006287rs121913669
3METp.Leu1195ValVAR_006288rs121913673
4METp.Val1220IleVAR_006289rs121913670
5METp.Asp1228AsnVAR_006290rs121913671
6METp.Asp1228HisVAR_006291
7METp.Tyr1230CysVAR_006292rs121913246
8METp.Tyr1230HisVAR_006293rs121913247
9METp.Met1250ThrVAR_006294rs121913245
10METp.Val1092IleVAR_032485rs786202724
11METp.His1094LeuVAR_032486
12METp.His1094ArgVAR_032487rs121913243
13METp.His1094TyrVAR_032488rs121913244
14METp.His1106AspVAR_032489
15METp.Tyr1230AspVAR_032491

Clinvar genetic disease variations for Renal Cell Carcinoma, Papillary:

5
id Gene Variation Type Significance SNP ID Assembly Location
1METNM_001127500.2(MET): c.3446T> C (p.Met1149Thr)SNVPathogenicrs121913668GRCh37Chr 7, 116418881: 116418881
2METNM_001127500.2(MET): c.3616G> T (p.Val1206Leu)SNVPathogenicrs121913669GRCh37Chr 7, 116422081: 116422081
3METNM_001127500.2(MET): c.3712G> A (p.Val1238Ile)SNVLikely pathogenic, Pathogenicrs121913670GRCh37Chr 7, 116423383: 116423383
4METNM_001127500.2(MET): c.3736G> A (p.Asp1246Asn)SNVPathogenicrs121913671GRCh37Chr 7, 116423407: 116423407
5METNM_001127500.2(MET): c.3743A> G (p.Tyr1248Cys)SNVPathogenicrs121913246GRCh37Chr 7, 116423414: 116423414
6METNM_001127500.2(MET): c.3637C> G (p.Leu1213Val)SNVPathogenicrs121913673GRCh37Chr 7, 116422102: 116422102
7METNM_001127500.2(MET): c.3335A> G (p.His1112Arg)SNVPathogenicrs121913243GRCh37Chr 7, 116417464: 116417464
8VHLNM_000551.3(VHL): c.548C> A (p.Ser183Ter)SNVPathogenicrs5030823GRCh37Chr 3, 10191555: 10191555
9ATMATM, IVS61DS, 2-BP INS, +2TAinsertionPathogenicChr na, -1: -1

Cosmic variations for Renal Cell Carcinoma, Papillary:

8 (show top 50)    (show all 186)
id Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA Conf
1COSM691METkidney,NS,carcinoma,papillary renal cell carcinomac.3803T>Cp.M1268T54
2COSM5011046COL6A3kidney,NS,carcinoma,papillary renal cell carcinomac.5464G>Ap.E1822K54
3COSM266367DDX54kidney,NS,carcinoma,papillary renal cell carcinomac.1543G>Ap.A515T54
4COSM4760527KSR2kidney,NS,carcinoma,papillary renal cell carcinomac.1679C>Tp.T560M54
5COSM5015023ATG2Akidney,NS,carcinoma,papillary renal cell carcinomac.5740G>Ap.G1914S54
6COSM5013688H1F0kidney,NS,carcinoma,papillary renal cell carcinomac.68C>Tp.T23I54
7COSM30383KMT2Dkidney,NS,carcinoma,papillary renal cell carcinomac.6185C>Tp.T2062I54
8COSM5012458SLC6A12kidney,NS,carcinoma,papillary renal cell carcinomac.1451A>Gp.N484S54
9COSM3121317CASRkidney,NS,carcinoma,papillary renal cell carcinomac.2590C>Tp.P864S54
10COSM5012862RTF1kidney,NS,carcinoma,papillary renal cell carcinomac.1725G>Tp.L575F54
11COSM5012058ZNF462kidney,NS,carcinoma,papillary renal cell carcinomac.7085G>Ap.R2362Q54
12COSM5010455AGRNkidney,NS,carcinoma,papillary renal cell carcinomac.4646G>Tp.G1549V54
13COSM5017225KMT2Akidney,NS,carcinoma,papillary renal cell carcinomac.6911A>Tp.K2304M54
14COSM5011074TOP2Bkidney,NS,carcinoma,papillary renal cell carcinomac.2758C>Ap.Q920K54
15COSM5014755REPIN1kidney,NS,carcinoma,papillary renal cell carcinomac.664G>Ap.V222M54
16COSM5014655ZBTB2kidney,NS,carcinoma,papillary renal cell carcinomac.931G>Ap.E311K54
17COSM43697TP53kidney,NS,carcinoma,papillary renal cell carcinomac.832C>Ap.P278T54
18COSM20754ATMkidney,NS,carcinoma,papillary renal cell carcinomac.4407T>Gp.I1469M54
19COSM5015634ARHGAP35kidney,NS,carcinoma,papillary renal cell carcinomac.481C>Tp.L161F54
20COSM1208713GPR39kidney,NS,carcinoma,papillary renal cell carcinomac.1192C>Tp.R398C54
21COSM5010858BIN1kidney,NS,carcinoma,papillary renal cell carcinomac.214G>Ap.V72I54
22COSM3724576METkidney,NS,carcinoma,papillary renal cell carcinomac.3616G>Tp.V1206L54
23COSM5010844GPAT2kidney,NS,carcinoma,papillary renal cell carcinomac.2023T>Cp.F675L54
24COSM689METkidney,NS,carcinoma,papillary renal cell carcinomac.3736G>Cp.D1246H54
25COSM5015402LDHDkidney,NS,carcinoma,papillary renal cell carcinomac.797C>Gp.P266R54
26COSM2231836NOTCH2NLkidney,NS,carcinoma,papillary renal cell carcinomac.403T>Gp.F135V54
27COSM5014999SLC39A13kidney,NS,carcinoma,papillary renal cell carcinomac.956G>Ap.G319D54
28COSM5011478RAPGEF6kidney,NS,carcinoma,papillary renal cell carcinomac.128G>Tp.R43L54
29COSM5012580MBD6kidney,NS,carcinoma,papillary renal cell carcinomac.1832T>Ap.L611H54
30COSM698METkidney,NS,carcinoma,papillary renal cell carcinomac.3335A>Tp.H1112L54
31COSM5012777WDR89kidney,NS,carcinoma,papillary renal cell carcinomac.260C>Ap.S87*54
32COSM697METkidney,NS,carcinoma,papillary renal cell carcinomac.3370C>Gp.H1124D54
33COSM5013654PDXKkidney,NS,carcinoma,papillary renal cell carcinomac.541G>Tp.D181Y54
34COSM5013149CCR7kidney,NS,carcinoma,papillary renal cell carcinomac.850C>Ap.L284M54
35COSM5013553PLCB4kidney,NS,carcinoma,papillary renal cell carcinomac.1555G>Tp.E519*54
36COSM5011528RBM22kidney,NS,carcinoma,papillary renal cell carcinomac.1162G>Tp.G388*54
37COSM18070VHLkidney,NS,carcinoma,papillary renal cell carcinomac.263G>Ap.W88*54
38COSM4791691DOCK11kidney,NS,carcinoma,papillary renal cell carcinomac.4220C>Gp.T1407R54
39COSM1226505SLC6A1kidney,NS,carcinoma,papillary renal cell carcinomac.1736G>Ap.R579H54
40COSM5011844CADPS2kidney,NS,carcinoma,papillary renal cell carcinomac.3103C>Ap.H1035N54
41COSM330952RYR3kidney,NS,carcinoma,papillary renal cell carcinomac.1606G>Tp.A536S54
42COSM5015411MAFkidney,NS,carcinoma,papillary renal cell carcinomac.169T>Gp.S57A54
43COSM3724575METkidney,NS,carcinoma,papillary renal cell carcinomac.3538C>Tp.H1180Y54
44COSM5017261NOS2kidney,NS,carcinoma,papillary renal cell carcinomac.2889-2A>Cp.?54
45COSM5017247ABL1kidney,NS,carcinoma,papillary renal cell carcinomac.2628G>Cp.R876S54
46COSM5015711TXNRD2kidney,NS,carcinoma,papillary renal cell carcinomac.1017G>Tp.Q339H54
47COSM5014421ATP10Dkidney,NS,carcinoma,papillary renal cell carcinomac.3255T>Ap.S1085R54
48COSM5011441FAM172Akidney,NS,carcinoma,papillary renal cell carcinomac.463C>Ap.H155N54
49COSM5012950CACNA1Hkidney,NS,carcinoma,papillary renal cell carcinomac.714C>Gp.F238L54
50COSM5013213TBX4kidney,NS,carcinoma,papillary renal cell carcinomac.1190C>Ap.S397*54

Expression for genes affiliated with Renal Cell Carcinoma, Papillary

About this section
LifeMap Discovery
Genes differentially expressed in tissues of Renal Cell Carcinoma, Papillary patients vs. healthy controls: 34 (show all 207)
id Gene Description Tissue Up/Dn Fold Change (log2) P value
1KCNJ1potassium channel, inwardly rectifying subfamily J, member 1Kidney-9.090.000
2FABP1fatty acid binding protein 1, liverKidney-8.850.000
3SLC12A1solute carrier family 12 (sodium/potassium/chloride transporter), member 1Kidney-8.840.000
4CALB1calbindin 1, 28kDaKidney-8.670.000
5SCNN1Gsodium channel, non voltage gated 1 gamma subunitKidney-8.580.000
6ALDOBaldolase B, fructose-bisphosphateKidney-8.530.000
7CLDN8claudin 8Kidney-8.440.000
8HPD4-hydroxyphenylpyruvate dioxygenaseKidney-8.060.000
9MUC15mucin 15, cell surface associatedKidney-7.910.000
10KNG1kininogen 1Kidney-7.820.000
11EGFepidermal growth factorKidney-7.810.000
12FXYD4FXYD domain containing ion transport regulator 4Kidney-7.680.000
13GSTA1glutathione S-transferase alpha 1Kidney-7.610.000
14NPHS2nephrosis 2, idiopathic, steroid-resistant (podocin)Kidney-7.600.000
15G6PCglucose-6-phosphatase, catalytic subunitKidney-7.500.000
16SLC7A13solute carrier family 7 (anionic amino acid transporter), member 13Kidney-7.320.000
17HMGCS23-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial)Kidney-7.220.000
18RALYLRALY RNA binding protein-likeKidney-7.100.000
19HSD11B2hydroxysteroid (11-beta) dehydrogenase 2Kidney-7.080.000
20FAM151Afamily with sequence similarity 151, member AKidney-7.080.000
21DNASE1deoxyribonuclease IKidney-7.000.000
22TMEM52Btransmembrane protein 52BKidney-6.940.000
23KCNJ10potassium channel, inwardly rectifying subfamily J, member 10Kidney-6.930.000
24IRX2iroquois homeobox 2Kidney-6.900.000
25PVALBparvalbuminKidney-6.660.000
26APOC1apolipoprotein C-IKidney+6.640.000
27SLC13A3solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3Kidney-6.600.000
28SLC26A7solute carrier family 26 (anion exchanger), member 7Kidney-6.510.000
29SLC4A1solute carrier family 4 (anion exchanger), member 1 (Diego blood group)Kidney-6.510.000
30TYRP1tyrosinase-related protein 1Kidney-6.460.000
31UPB1ureidopropionase, betaKidney-6.390.000
32CYP4A11cytochrome P450, family 4, subfamily A, polypeptide 11Kidney-6.380.000
33SOSTsclerostinKidney-6.350.000
34HEPACAM2HEPACAM family member 2Kidney-6.330.000
35UMODuromodulinKidney-6.210.000
36SCNN1Bsodium channel, non voltage gated 1 beta subunitKidney-6.210.000
37SLC22A6solute carrier family 22 (organic anion transporter), member 6Kidney-6.190.000
38GCgroup-specific component (vitamin D binding protein)Kidney-6.190.000
39MFSD4major facilitator superfamily domain containing 4Kidney-6.190.000
40PDE1Aphosphodiesterase 1A, calmodulin-dependentKidney-6.180.002
41GPC5glypican 5Kidney-6.170.000
42SFRP1secreted frizzled-related protein 1Kidney-6.110.000
43MPPED2metallophosphoesterase domain containing 2Kidney-6.070.000
44HS6ST2heparan sulfate 6-O-sulfotransferase 2Kidney-6.060.004
45SLC22A8solute carrier family 22 (organic anion transporter), member 8Kidney-6.040.000
46WNK4WNK lysine deficient protein kinase 4Kidney-6.030.000
47RHCGRh family, C glycoproteinKidney-6.010.000
48CRHBPcorticotropin releasing hormone binding proteinKidney-5.990.000
49EHFets homologous factorKidney-5.980.000
50C16orf89chromosome 16 open reading frame 89Kidney-5.970.000
51DIO1deiodinase, iodothyronine, type IKidney-5.880.000
52PRDM16PR domain containing 16Kidney-5.880.000
53TMEM213transmembrane protein 213Kidney-5.850.000
54PROM2prominin 2Kidney-5.830.000
55RERGLRERG/RAS-likeKidney-5.780.000
56CLIC5chloride intracellular channel 5Kidney-5.770.000
57KCNN3potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3Kidney-5.770.000
58TNFAIP6tumor necrosis factor, alpha-induced protein 6Kidney+5.760.001
59TMPRSS2transmembrane protease, serine 2Kidney-5.750.000
60ENPP6ectonucleotide pyrophosphatase/phosphodiesterase 6Kidney-5.690.000
61GAD1glutamate decarboxylase 1 (brain, 67kDa)Kidney-5.680.000
62SLC14A1solute carrier family 14 (urea transporter), member 1 (Kidd blood group)Kidney-5.680.000
63MYH11myosin, heavy chain 11, smooth muscleKidney-5.660.000
64NELL1neural EGFL like 1Kidney-5.630.000
65LOC284578uncharacterized LOC284578Kidney-5.610.000
66ATP6V1G3ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3Kidney-5.600.000
67MUC20mucin 20, cell surface associatedKidney-5.560.000
68FAM3Bfamily with sequence similarity 3, member BKidney-5.560.000
69TMEM174transmembrane protein 174Kidney-5.550.000
70SLC4A9solute carrier family 4, sodium bicarbonate cotransporter, member 9Kidney-5.550.000
71RASD1RAS, dexamethasone-induced 1Kidney-5.550.000
72ATP6V0A4ATPase, H+ transporting, lysosomal V0 subunit a4Kidney-5.550.000
73SLC5A12solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12Kidney-5.540.001
74SLC22A12solute carrier family 22 (organic anion/urate transporter), member 12Kidney-5.530.000
75C1orf168chromosome 1 open reading frame 168Kidney-5.490.000
76PTGER3prostaglandin E receptor 3 (subtype EP3)Kidney-5.470.000
77SLC12A3solute carrier family 12 (sodium/chloride transporter), member 3Kidney-5.420.000
78TCF21transcription factor 21Kidney-5.410.000
79ESRRBestrogen-related receptor betaKidney-5.410.000
80CYP4A22cytochrome P450, family 4, subfamily A, polypeptide 22Kidney-5.380.000
81ALBalbuminKidney-5.370.000
82CTXN3cortexin 3Kidney-5.370.000
83C2orf40chromosome 2 open reading frame 40Kidney-5.350.000
84HAO2hydroxyacid oxidase 2 (long chain)Kidney-5.320.001
85NOS1nitric oxide synthase 1 (neuronal)Kidney-5.310.000
86EYA4EYA transcriptional coactivator and phosphatase 4Kidney-5.290.001
87PCK1phosphoenolpyruvate carboxykinase 1 (soluble)Kidney-5.290.000
88FABP4fatty acid binding protein 4, adipocyteKidney-5.280.000
89MECOMMDS1 and EVI1 complex locusKidney-5.270.000
90TMEM178Atransmembrane protein 178AKidney-5.260.001
91RENreninKidney-5.260.000
92ZNF44zinc finger protein 44Kidney-5.250.000
93CRYAAcrystallin, alpha AKidney-5.240.000
94SERPINA5serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5Kidney-5.240.000
95ADH1Balcohol dehydrogenase 1B (class I), beta polypeptideKidney-5.220.000
96FGF9fibroblast growth factor 9Kidney-5.190.000
97RAB25RAB25, member RAS oncogene familyKidney-5.180.000
98UPP2uridine phosphorylase 2Kidney-5.180.001
99AQP2aquaporin 2 (collecting duct)Kidney-5.150.000
100TPCN2two pore segment channel 2Kidney-5.140.000
101NTRK2neurotrophic tyrosine kinase, receptor, type 2Kidney-5.120.001
102ATP6V1B1ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1Kidney-5.110.000
103AFMafaminKidney-5.110.000
104TBX2T-box 2Kidney-5.090.000
105STAP1signal transducing adaptor family member 1Kidney-5.070.000
106RALGAPA2Ral GTPase activating protein, alpha subunit 2 (catalytic)Kidney-5.050.000
107MMEmembrane metallo-endopeptidaseKidney-5.040.002
108AGXTalanine-glyoxylate aminotransferaseKidney-5.040.000
109ERBB4erb-b2 receptor tyrosine kinase 4Kidney-5.040.003
110SLC22A7solute carrier family 22 (organic anion transporter), member 7Kidney-5.040.001
111MT1Gmetallothionein 1GKidney-5.020.000
112TCEAL2transcription elongation factor A (SII)-like 2Kidney-4.990.000
113CYP4F2cytochrome P450, family 4, subfamily F, polypeptide 2Kidney-4.990.000
114XPNPEP2X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-boundKidney-4.990.000
115WT1Wilms tumor 1Kidney-4.990.000
116C7complement component 7Kidney-4.960.000
117LOC285556uncharacterized LOC285556Kidney-4.940.000
118TMEM45Btransmembrane protein 45BKidney-4.930.001
119ATP6V1C2ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2Kidney-4.920.000
120BHMTbetaine--homocysteine S-methyltransferaseKidney-4.920.001
121DUSP9dual specificity phosphatase 9Kidney-4.920.000
122TFAP2Atranscription factor AP-2 alpha (activating enhancer binding protein 2 alpha)Kidney-4.910.000
123VAT1Lvesicle amine transport 1-likeKidney-4.910.000
124EMCNendomucinKidney-4.900.000
125TSPAN8tetraspanin 8Kidney-4.900.006
126SIM2single-minded family bHLH transcription factor 2Kidney-4.900.000
127PLGplasminogenKidney-4.890.000
128DMRT2doublesex and mab-3 related transcription factor 2Kidney-4.890.000
129KHKketohexokinase (fructokinase)Kidney-4.890.000
130HRGhistidine-rich glycoproteinKidney-4.880.000
131ACPPacid phosphatase, prostateKidney-4.860.000
132TMEM72transmembrane protein 72Kidney-4.850.000
133DACH1dachshund family transcription factor 1Kidney-4.850.001
134PTGDSprostaglandin D2 synthase 21kDa (brain)Kidney-4.830.001
135AHNAK2AHNAK nucleoprotein 2Kidney+4.830.000
136IRX1iroquois homeobox 1Kidney-4.810.000
137FOLH1folate hydrolase (prostate-specific membrane antigen) 1Kidney-4.810.000
138ATP6V0D2ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2Kidney-4.800.000
139LOC149703uncharacterized LOC149703Kidney-4.800.001
140TOP2Atopoisomerase (DNA) II alphaKidney+4.780.001
141GATA3GATA binding protein 3Kidney-4.780.000
142FGF1fibroblast growth factor 1 (acidic)Kidney-4.760.000
143ELF5E74-like factor 5 (ets domain transcription factor)Kidney-4.760.000
144KCNE1potassium channel, voltage gated subfamily E regulatory beta subunit 1Kidney-4.750.000
145SEMA3Gsema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3GKidney-4.740.000
146CASRcalcium-sensing receptorKidney-4.740.001
147ANGPTL3angiopoietin-like 3Kidney-4.720.000
148SLC34A1solute carrier family 34 (type II sodium/phosphate cotransporter), member 1Kidney-4.710.000
149PAHphenylalanine hydroxylaseKidney-4.710.000
150ERICH4glutamate-rich 4Kidney-4.700.000
151CLCNKBchloride channel, voltage-sensitive KbKidney-4.700.000
152TFAP2Btranscription factor AP-2 beta (activating enhancer binding protein 2 beta)Kidney-4.690.001
153SLC13A2solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2Kidney-4.680.001
154CA4carbonic anhydrase IVKidney-4.670.000
155FCN3ficolin (collagen/fibrinogen domain containing) 3Kidney-4.670.000
156TFPI2tissue factor pathway inhibitor 2Kidney+4.590.000
157SLFN13schlafen family member 13Kidney+4.520.000
158CCL18chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)Kidney+4.490.029
159VCANversicanKidney+4.450.003
160ALOX5arachidonate 5-lipoxygenaseKidney+4.430.000
161LCN2lipocalin 2Kidney+4.330.000
162LRRC20leucine rich repeat containing 20Kidney+4.250.000
163C3complement component 3Kidney+4.240.001
164ABHD11abhydrolase domain containing 11Kidney+4.000.000
165HK2hexokinase 2Kidney+3.980.000
166SEC16BSEC16 homolog B, endoplasmic reticulum export factorKidney+3.980.000
167ABCB4ATP-binding cassette, sub-family B (MDR/TAP), member 4Kidney+3.910.002
168NRTNneurturinKidney+3.840.002
169DNM1dynamin 1Kidney+3.810.000
170LOC100289026uncharacterized LOC100289026Kidney+3.800.002
171HOXA1homeobox A1Kidney+3.800.000
172LYPD1LY6/PLAUR domain containing 1Kidney+3.760.019
173C3orf67chromosome 3 open reading frame 67Kidney+3.760.000
174TREM2triggering receptor expressed on myeloid cells 2Kidney+3.760.000
175HAVCR1hepatitis A virus cellular receptor 1Kidney+3.670.000
176HTRA4HtrA serine peptidase 4Kidney+3.620.002
177CXCL6chemokine (C-X-C motif) ligand 6Kidney+3.610.036
178F12coagulation factor XII (Hageman factor)Kidney+3.570.004
179BCANbrevicanKidney+3.560.001
180CCND2cyclin D2Kidney+3.550.000
181LRRN4leucine rich repeat neuronal 4Kidney+3.520.000
182C15orf48chromosome 15 open reading frame 48Kidney+3.500.015
183BRIP1BRCA1 interacting protein C-terminal helicase 1Kidney+3.500.001
184NAV3neuron navigator 3Kidney+3.480.007
185TPX2TPX2, microtubule-associatedKidney+3.420.013
186NNMTnicotinamide N-methyltransferaseKidney+3.420.004
187SCG5secretogranin VKidney+3.380.020
188HS3ST1heparan sulfate (glucosamine) 3-O-sulfotransferase 1Kidney+3.370.004
189HIST1H2AGhistone cluster 1, H2agKidney+3.350.024
190C1orf186chromosome 1 open reading frame 186Kidney+3.320.001
191MNX1motor neuron and pancreas homeobox 1Kidney+3.240.000
192ONECUT2one cut homeobox 2Kidney+3.230.013
193CD86CD86 moleculeKidney+3.200.001
194TTKTTK protein kinaseKidney+3.190.012
195NEK2NIMA-related kinase 2Kidney+3.160.033
196KIF20Akinesin family member 20AKidney+3.140.027
197TEN1TEN1 CST complex subunitKidney+3.140.013
198TLCD2TLC domain containing 2Kidney+3.130.007
199LOC340340uncharacterized LOC340340Kidney+3.100.023
200UNC5Aunc-5 netrin receptor AKidney+3.070.045
201FANCIFanconi anemia, complementation group IKidney+3.060.011
202CDHR1cadherin-related family member 1Kidney+3.060.026
203MIR155HGMIR155 host geneKidney+3.040.018
204CDH6cadherin 6, type 2, K-cadherin (fetal kidney)Kidney+3.030.000
205ARL11ADP-ribosylation factor-like 11Kidney+3.030.028
206TPK1thiamin pyrophosphokinase 1Kidney+3.020.002
207BCL2A1BCL2-related protein A1Kidney+3.020.022

Search GEO for disease gene expression data for Renal Cell Carcinoma, Papillary.

Pathways for genes affiliated with Renal Cell Carcinoma, Papillary

About this section

Pathways related to Renal Cell Carcinoma, Papillary according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
10.0CLTC, KIT, MITF
29.9AMACR, ASPSCR1, CA9, FH
39.8ASPSCR1, ATM, MET, PAX8, PRCC, TFE3
49.6FH, KIT, MET, MITF, PAX8, VHL

GO Terms for genes affiliated with Renal Cell Carcinoma, Papillary

About this section

Cellular components related to Renal Cell Carcinoma, Papillary according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1paraspecklesGO:004238210.2NONO, SFPQ

Biological processes related to Renal Cell Carcinoma, Papillary according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1regulation of osteoclast differentiationGO:004567010.2MITF, TFE3
2melanocyte differentiationGO:003031810.2KIT, MITF
3replicative senescenceGO:00903999.9ATM, MME

Molecular functions related to Renal Cell Carcinoma, Papillary according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1protein dimerization activityGO:004698310.0ATM, MITF, TFE3, TFEB
2transcription regulatory region DNA bindingGO:00442129.7PAX8, SFPQ, TFE3, TFEB

Sources for Renal Cell Carcinoma, Papillary

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet